A rare entity in multiple myeloma: six nerve paralysis
- PMID: 25332540
- PMCID: PMC4192163
- DOI: 10.1007/s12288-013-0252-5
A rare entity in multiple myeloma: six nerve paralysis
Abstract
Ophthalmic involvement appears rarely in multiple myeloma (MM). Ophthalmic findings are mostly noted as complications caused by disease or treatment. MM-associated with 6th nerve paralysis is a rare entity. Bortezomib, one of the novel agents used to treat MM, has neurotoxic effect and may cause permanent nerve damage. Herein, we report a 50-year-old male patient with MM who developed the 6th nerve paralysis while receiving bortezomib and discuss its relevant causes.
Keywords: Bortezomib; Multiple myeloma; The 6th nerve paralysis.
Figures
References
-
- Dispenzieri A, Lacy MQ, Greipp PR. Multiple Myeloma. In: Greer JP, Foerster J, Rodgers GM, Paraskevas F, Glader B, Daniel AA, Means RT, editors. Wintrobe’s Clinical Hematology. Philadelphia: Lippincott Williams & Wilkins; 2009. pp. 2372–2420.
-
- Hoffbrand AV, Catovsky D, Tuddenham EGD, Green AR. Multiple Myeloma. In: San-Miguel J, Blade J, editors. Postgraduate Haematology. 6. London: Wiley-Blackwell; 2011. pp. 577–598.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources